AAAAAA
Results:
1-20
|
Results: 20
Authors:
Shad, JA
McHutchison, JG
Citation: Ja. Shad et Jg. Mchutchison, Current treatment of hepatitis C, GASTR HEPAT, 8, 2002, pp. 187-216
Authors:
McHutchison, JG
Shad, JA
Gordon, SC
Morgan, TR
Ling, MH
Garaud, JJ
Albrecht, JK
Dienstag, JL
Citation: Jg. Mchutchison et al., Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy, J VIRAL HEP, 8(6), 2001, pp. 414-420
Authors:
Bekkering, FC
Stalgis, C
McHutchison, JG
Brouwer, JT
Perelson, AS
Citation: Fc. Bekkering et al., Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model, HEPATOLOGY, 33(2), 2001, pp. 419-423
Authors:
Chang, KM
Thimme, R
Melpolder, JJ
Oldach, D
Pemberton, J
Moorhead-Loudis, J
McHutchison, JG
Alter, HJ
Chisari, FV
Citation: Km. Chang et al., Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection, HEPATOLOGY, 33(1), 2001, pp. 267-276
Authors:
McHutchison, JG
Ponnudurai, R
Bylund, DL
Anguiano, A
Pockros, PJ
Mondala, T
Wilkes, LB
Citation: Jg. Mchutchison et al., Prednisone withdrawal followed by interferon alpha for treatment of chronic Hepatitis C infection - Results of a randomized controlled trial, J CLIN GAST, 32(2), 2001, pp. 133-137
Authors:
McHutchison, JG
Ware, JE
Bayliss, MS
Pianko, S
Albrecht, JK
Cort, S
Yang, I
Neary, MP
Citation: Jg. Mchutchison et al., The effects of interferon alpha-2b in combination with ribavirin on healthrelated quality of life and work productivity, J HEPATOL, 34(1), 2001, pp. 140-147
Authors:
Blatt, LM
Mutchnick, MG
Tong, MJ
Klion, FM
Lebovics, E
Freilich, B
Bach, N
Smith, C
Herrera, J
Tobias, H
Conrad, A
Schmid, P
McHutchison, JG
Citation: Lm. Blatt et al., Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States, J VIRAL HEP, 7(3), 2000, pp. 196-202
Authors:
McHutchison, JG
Younossi, Z
Citation: Jg. Mchutchison et Z. Younossi, Treatment strategies for hepatitis C: Making the best of limited options, CLEV CLIN J, 67(7), 2000, pp. 476-480
Authors:
McHutchison, JG
Blatt, LM
De Medina, M
Craig, JR
Conrad, A
Schiff, ER
Tong, MJ
Citation: Jg. Mchutchison et al., Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology, J GASTR HEP, 15(8), 2000, pp. 945-951
Authors:
Pianko, S
McHutchison, JG
Citation: S. Pianko et Jg. Mchutchison, Treatment of hepatitis C with interferon and ribavirin, J GASTR HEP, 15(6), 2000, pp. 581-586
Authors:
Gordon, SC
Fang, JWS
Silverman, AL
McHutchison, JG
Albrecht, JK
Citation: Sc. Gordon et al., The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C, HEPATOLOGY, 32(2), 2000, pp. 400-404
Authors:
Younossi, ZM
Singer, ME
McHutchison, JG
Shermock, KM
Citation: Zm. Younossi et al., Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment ofchronic hepatitis C - Reply, HEPATOLOGY, 31(3), 2000, pp. 807-808
Authors:
Wong, JB
McQuillan, GM
McHutchison, JG
Poynard, T
Citation: Jb. Wong et al., Estimating future hepatitis C morbidity, mortality, and costs in the United States, AM J PUB HE, 90(10), 2000, pp. 1562-1569
Authors:
McHutchison, JG
Poynard, T
Pianko, S
Gordon, SC
Reid, AE
Dienstag, J
Morgan, T
Yao, RJ
Albrecht, J
Citation: Jg. Mchutchison et al., The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C, GASTROENTY, 119(5), 2000, pp. 1317-1323
Authors:
Duchini, A
McHutchison, JG
Pockros, PJ
Citation: A. Duchini et al., LKM-positive autoimmune hepatitis in the western United States: A case series, AM J GASTRO, 95(11), 2000, pp. 3238-3241
Authors:
McHutchison, JG
Giannelli, G
Nyberg, L
Blatt, LM
Waite, K
Mischkot, P
Pianko, S
Conrad, A
Grint, P
Citation: Jg. Mchutchison et al., A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection, J INTERF CY, 19(11), 1999, pp. 1265-1270
Authors:
McHutchison, JG
Poynard, T
Citation: Jg. Mchutchison et T. Poynard, Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C (vol 19, pg 57, 1999), SEM LIV DIS, 19(3), 1999, pp. 353-353
Authors:
McHutchison, JG
Poynard, T
Citation: Jg. Mchutchison et T. Poynard, Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C, SEM LIV DIS, 19, 1999, pp. 57-65
Authors:
Younossi, ZM
Singer, ME
McHutchison, JG
Shermock, KM
Citation: Zm. Younossi et al., Cost effectiveness of interferon alpha 2b combined with ribavirin for the treatment of chronic hepatitis C, HEPATOLOGY, 30(5), 1999, pp. 1318-1324
Authors:
McHutchison, JG
Blatt, LM
Ponnudurai, R
Goodarzi, K
Russell, J
Conrad, A
Citation: Jg. Mchutchison et al., Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection, J MED VIROL, 57(4), 1999, pp. 351-355
Risultati:
1-20
|